adverse event reporting
Saudi FDA: Working with Industry to Improve the Reporting of Adverse Reactions
December 13 by Andrea CharlesIn this interview Dr. Nasser Al-Qahtani, Head, Adverse Drug Reactions Evaluation Department Saudi FDA speaks to Andrea Charles from Pharma IQ, about the Saudi FDA pharmacovigilance system and wha...
Embracing Pharmacovigilance with Technology
May 18 by Pharma IQMany companies in the pharmaceutical industry have provisions in place to deal with pharmacovigilance and other so-called late phase issues, as they realise the important role they can play in boosti...
Would ASEAN Accept Data and Reviews that Cross Borders?
August 11 by Bryan CamoensRobert Lim, Head of Haematology and Oncology, for the National University Cancer Institute, speaks exclusively to Bryan Camoens from Pharma IQ, on the fundamental difference between pharmacodili...